Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 118317
Published online Jun 27, 2026. doi: 10.4240/wjgs.118317
Published online Jun 27, 2026. doi: 10.4240/wjgs.118317
Table 1 Comparison of baseline data between the mirabilite and control groups, n (%)/mean ± SD
| Variable | Mirabilite group | Control group | P value |
| Gender | 0.688 | ||
| Male | 92 (30.56) | 97 (32.23) | |
| Female | 58 (19.27) | 54 (17.94) | |
| Age, years | 60.82 ± 10.49 | 61.52 ± 10.19 | 0.620 |
| BMI, kg/m2 | 22.87 ± 2.92 | 22.80 ± 2.95 | 0.706 |
| ASA | 0.577 | ||
| II | 13 (4.32) | 17 (5.64) | |
| III | 137 (45.51) | 134 (44.52) | |
| Comorbidities | |||
| Diabetes mellitus | 16 (10.67) | 18 (11.92) | 0.731 |
| Chronic lung disease | 11 (7.33) | 10 (6.62) | 0.783 |
| Hypertension | 22 (14.67) | 25 (16.56) | 0.654 |
| Coronary heart disease | 7 (4.67) | 6 (3.97) | 0.741 |
| Preoperative hypoalbuminemia (< 35 g/L) | 14 (9.33) | 18 (11.92) | 0.467 |
| Surgical site | 0.426 | ||
| Stomach | 54 (17.94) | 61 (20.26) | |
| Rectum | 45 (14.95) | 45 (14.95) | |
| Right hemicolon | 26 (8.64) | 17 (5.65) | |
| Left hemicolon | 9 (2.99) | 6 (1.99) | |
| Sigmoid colon | 16 (5.31) | 22 (7.31) |
Table 2 Comparison of perioperative indexes between the mirabilite and control groups, median (interquartile rage)/n (%)/mean ± SD
| Variable | Mirabilite group | Control group | P value |
| Surgical duration, min | 161.0 (67-375) | 165.0 (50-435) | 0.694 |
| Intraoperative blood loss, mL | 100.0 (5-960) | 100.0 (20-1000) | 0.377 |
| Incision length, cm | 6.0 (4-12) | 6.0 (4-10) | 0.379 |
| Time to first flatus, hours | 38 (18-75) | 57.0 (17-90) | < 0.001 |
| Postoperative length of stay, days | 8.5 (7-36) | 9.0 (7-33) | 0.028 |
| Postoperative complication | 7 (2.33) | 12 (3.99) | 0.335 |
| Bowel obstruction | 1 | 3 | |
| Anastomotic leakage | 3 | 6 | |
| Pneumonia | 3 | 3 | |
| SSI | 15 (4.98) | 26 (8.64) | 0.042 |
| Superficial SSI | 12 | 22 | |
| Deep SSI | 3 | 4 | |
| Organ/space SSI | 0 | 0 | |
| Postoperative serum albumin level, g/L | |||
| Day 1 | 32.52 ± 3.88 | 32.12 ± 3.38 | 0.338 |
| Day 4 | 34.77 ± 3.90 | 34.92 ± 3.99 | 0.741 |
Table 3 Comparison of postoperative C-reactive protein, drainage, and Visual Analog Scale scores between the mirabilite and control groups, mean ± SD
| Variable | Mirabilite group | Control group | P value |
| C-reactive protein, mg/L | 0.038 | ||
| Day 1 | 43.58 ± 33.49 | 45.83 ± 37.90 | |
| Day 4 | 93.14 ± 53.51 | 101.92 ± 53.33 | |
| Day 7 | 47.35 ± 40.33 | 70.70 ± 50.68 | |
| VAS score | 0.027 | ||
| Day 1 | 1.71 ± 0.74 | 2.26 ± 0.72 | |
| Day 2 | 1.39 ± 0.61 | 2.09 ± 0.83 | |
| Day 3 | 1.18 ± 0.43 | 1.74 ± 0.76 | |
| Drainage, mL | < 0.01 | ||
| Day 1 | 95.63 ± 5.92 | 98.71 ± 5.73 | |
| Day 2 | 66.63 ± 4.72 | 68.25 ± 4.84 | |
| Day 3 | 45.27 ± 4.87 | 47.58 ± 4.93 | |
| Day 4 | 27.97 ± 5.02 | 27.75 ± 7.70 | |
| Day 5 | 14.80 ± 4.17 | 15.76 ± 6.83 | |
| Day 6 | 8.67 ± 3.74 | 9.14 ± 3.64 | |
| Day 7 | 6.17 ± 2.92 | 5.63 ± 1.76 |
- Citation: Li TY, Zou RX, Min FZ, Luo AL, Ye SP. Application of mirabilite in gastrointestinal surgery: A randomized controlled trial. World J Gastrointest Surg 2026; 18(6): 118317
- URL: https://www.wjgnet.com/1948-9366/full/v18/i6/118317.htm
- DOI: https://dx.doi.org/10.4240/wjgs.118317